Click here for flash
Register for Updates
Be notified when new content and features are added to CLLPerspectives.com. Go
CLL Perspectives features the latest news and clinical information about CLL, brought to you in part by our advisory board of leading CLL experts. Access up-to-date clinical reviews, download educational resources and hear from our advisors on key topics in CLL. Our goal is to help you achieve better outcomes for your CLL patients. Learn more about us.
Featured Perspectives

Farrukh Awan, MD, MS
John C. Byrd, MD

Staging and Prognostic Factors in CLL

Thus far, no study has shown a survival advantage with early treatment in patients with CLL and a subset of CLL patients will never require therapy. This has led to the research efforts in CLL that have identified several specific biologic or clinical prognostic factors that predict time to progression and overall survival. With these recent...

Constantine S. Tam, MB, BS Susan Lerner, MS
Michael J. Keating, MB, BS

New Prognostic Markers in CLL

The recent proliferation of new "prognostic markers" in chronic lymphocytic leukemia (CLL) has provided valuable insights into the biology of the disease.1 In particular, significant survival differences when patients are classified by immunoglobulin heavy chain variable region (IGVH) mutation status2,3, fluorescent in-situ hybridization (FISH)...
Read more Read more

News & Commentary - provided by Medworm

 
Spleen Tyrosine Kinase Is Overexpressed and Represents a Potential Therapeutic Target in Chronic Lymphocytic Leukemia

In this study, we investigated the expression of spleen tyrosine kinase (SYK), a key component of the B-cell receptor signaling pathway, in CLL and its role in apoptosis. Gene expression profiling identified enhanced expression of SYK and downstream pathways in CLL compared with healthy B cells. Immunoblotting showed increased expression and phosphorylation of SYK, PLC2, signal transducers and activators of transcription 3, and extracellular signal regulated kinase 1/2 in CLL compared with healthy B cells, suggesting enhanced activation of these mediators in CLL. SYK inhibitors reduced phosphorylation of SYK downstream targets and induced apoptosis in primary CLL cells. With respect to prognostic factors, SYK inhibitors exerted stronger cytotoxic effects in unmutated and ZAP70+ cases. Cyto...

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

Source: Cancer Research - Tuesday, June 30, 2009

How would I manage a sample submitted for flow cytometry analysis for suspicious chronic lymphocytic leukaemia

Samples submitted for a suspect of chronic lymphocytic leukemia are the most frequently observed in flow cytometry laboratories. These cases require not only a precise and prompt diagnosis but also an evaluation on the possibility of performing additional prognostic tests. We will propose two sequential flow cytometry panels and a personal opinion on how to manage these samples for both diagnostic and prognostic assessment, taking into account the published guidelines and recommendations. Copyright © 2009 John Wiley & Sons, Ltd. (Source: Hematological Oncology)

Source: Hematological Oncology - Tuesday, June 30, 2009

Common genetic variants in candidate genes and risk of familial lymphoid malignancies

Familial aggregation, linkage and case[ndash]control studies support the role of germline genes in the aetiology of lymphoid malignancies. To further examine the role of genetic variation underlying susceptibility, we analysed 1536 single nucleotide polymorphisms in 152 genes involved in apoptosis, DNA repair, immune response and oxidative stress pathways among a unique sample of 165 unrelated familial cases including patients with chronic lymphocytic leukaemia (CLL), Waldenström macroglobulinaemia (WM) and Hodgkin lymphoma (HL), and 107 spouse controls. We confirmed previous studies showing a polymorphism in the IL10 promoter (rs1800890/-3575T>A) to be associated with non-Hodgkin lymphoma, as this allele was found to be associated with both CLL and WM. We also confirmed the role of IL6 v...

Source: British Journal of Haematology - Tuesday, June 30, 2009

Clinical pathological and epidemiological assessment of morphologically and immunologically confirmed canine leukaemia

This study strengthens the hypothesis that acute leukaemias give rise to more profound cytopenias, affecting more cell lines, than chronic leukaemias. (Source: Veterinary and Comparative Oncology)

Source: Veterinary and Comparative Oncology - Tuesday, June 30, 2009

Combined PER2 and CRY1 expression predicts outcome in chronic lymphocytic leukemia

The objective of this study was to confirm previous results regarding the differential expression and prognostic significance of the circadian gene CRY1 in chronic lymphocytic leukemia (CLL) patients and its relationship with the expression of other circadian genes and well-established prognostic markers. We also aimed to investigate whether the peripheral circadian machinery may be deregulated in CLL cells. The expression of CRY1, PER1, and PER2 was determined by real-time reverse transcriptase polymerase chain reaction (RT-PCR) in 116 CLL patients. The expression at sequential time points over a 24-h period was measured in six CLL patients and six normal donors. We confirmed the differential expression of CRY1 in ZAP-70+/CD38+ and ZAP-70[minus]/CD38[minus] CLL samples. Subgroups formed a...

Source: European Journal of Haematology - Monday, June 29, 2009